72.51
0.33%
-0.24
시장 영업 전:
72.60
0.09
+0.12%
전일 마감가:
$72.75
열려 있는:
$73.5
하루 거래량:
1.66M
Relative Volume:
1.05
시가총액:
$12.97B
수익:
$342.96M
순이익/손실:
$-864.29M
주가수익비율:
-13.06
EPS:
-5.55
순현금흐름:
$-636.03M
1주 성능:
+11.13%
1개월 성능:
-1.81%
6개월 성능:
-4.01%
1년 성능:
+151.68%
Insmed Inc Stock (INSM) Company Profile
명칭
Insmed Inc
전화
908-977-9900
주소
700 US HIGHWAY 202/206, BRIDGEWATER, NJ
INSM을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
INSM
Insmed Inc
|
72.51 | 12.97B | 342.96M | -864.29M | -636.03M | -5.55 |
VRTX
Vertex Pharmaceuticals Inc
|
422.00 | 108.68B | 10.63B | -479.80M | -1.35B | -1.99 |
REGN
Regeneron Pharmaceuticals Inc
|
681.58 | 74.90B | 13.85B | 4.65B | 3.32B | 40.41 |
ARGX
Argen X Se Adr
|
640.52 | 38.30B | 1.86B | -40.29M | -1.28B | -0.85 |
ALNY
Alnylam Pharmaceuticals Inc
|
246.27 | 31.76B | 2.09B | -332.26M | 16.06M | -2.62 |
BNTX
Biontech Se Adr
|
111.93 | 26.83B | 3.30B | -501.07M | 1.03B | -2.1146 |
Insmed Inc Stock (INSM) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2024-04-23 | 개시 | Truist | Buy |
2024-02-15 | 개시 | Wolfe Research | Outperform |
2023-12-08 | 개시 | Wells Fargo | Overweight |
2023-11-20 | 재개 | JP Morgan | Overweight |
2023-07-26 | 개시 | Guggenheim | Buy |
2022-12-09 | 개시 | Mizuho | Buy |
2022-12-07 | 개시 | Barclays | Overweight |
2022-11-18 | 개시 | BofA Securities | Buy |
2022-04-27 | 개시 | Goldman | Buy |
2021-12-06 | 개시 | JP Morgan | Overweight |
2021-10-19 | 재개 | Monness Crespi & Hardt | Buy |
2021-10-19 | 재개 | Morgan Stanley | Overweight |
2021-10-08 | 개시 | Cantor Fitzgerald | Overweight |
2021-04-26 | 재개 | Credit Suisse | Outperform |
2020-12-17 | 개시 | Berenberg | Buy |
2020-10-12 | 재개 | Stifel | Buy |
2019-09-03 | 개시 | Goldman | Buy |
2019-04-09 | 재확인 | H.C. Wainwright | Buy |
2019-02-15 | 업그레이드 | JMP Securities | Mkt Perform → Mkt Outperform |
2019-01-17 | 업그레이드 | Goldman | Neutral → Buy |
2019-01-02 | 개시 | Canaccord Genuity | Buy |
2018-08-06 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
2018-07-23 | 개시 | Goldman | Neutral |
2018-04-23 | 업그레이드 | Credit Suisse | Neutral → Outperform |
2018-03-21 | 개시 | Morgan Stanley | Overweight |
2018-01-18 | 개시 | Credit Suisse | Neutral |
2017-09-05 | 재확인 | Evercore ISI | Outperform |
2017-08-17 | 개시 | Evercore ISI | Outperform |
2017-07-11 | 개시 | Robert W. Baird | Outperform |
2016-03-15 | 개시 | Stifel | Buy |
2015-11-09 | 다운그레이드 | UBS | Buy → Neutral |
2015-10-06 | 재확인 | H.C. Wainwright | Buy |
2015-06-09 | 개시 | Citigroup | Neutral |
2014-03-26 | 재확인 | HC Wainwright | Buy |
모두보기
Insmed Inc 주식(INSM)의 최신 뉴스
Insmed CEO William Lewis sells shares worth $2.71 million - MSN
Insmed Incorporated (NASDAQ:INSM) Short Interest Up 18.7% in December - MarketBeat
Is Insmed (NASDAQ:INSM) Using Debt Sensibly? - Simply Wall St
Insmed chief medical officer sells $95,108 in stock - MSN
Is Insmed Incorporated (INSM) One of the Best Russell 2000 Stocks to Invest in According to Analysts? - Yahoo Finance
Insmed (FRA:IM8N) Shares Outstanding (EOP) : 178.8 Mil (As of Sep. 2024) - GuruFocus.com
Insmed's chief people strategy officer sells $59,923 in stock - MSN
Goldman Sachs Sees High Merger Odds For This Large-Cap Biopharma In Trump 2.0 Era: Retail Has Been Alert - MSN
Insmed Incorporated (NASDAQ:INSM) Insider Sells $95,108.48 in Stock - MarketBeat
Insmed Incorporated (NASDAQ:INSM) CEO William Lewis Sells 31,805 Shares of Stock - MarketBeat
Insmed COO Roger Adsett sells $100,125 in stock - MSN
Hennion & Walsh Asset Management Inc. Sells 43,522 Shares of Insmed Incorporated (NASDAQ:INSM) - MarketBeat
Insmed chief medical officer sells $95,108 in stock By Investing.com - Investing.com Australia
Assenagon Asset Management S.A. Has $36.26 Million Position in Insmed Incorporated (NASDAQ:INSM) - MarketBeat
Insider Sell: Roger Adsett Sells 1,457 Shares of Insmed Inc (INS - GuruFocus.com
Insider Sell: Schaeffer Orlov S Nicole Sells Shares of Insmed In - GuruFocus.com
Insmed's chief people strategy officer sells $59,923 in stock By Investing.com - Investing.com Australia
Insmed COO Roger Adsett sells $100,125 in stock By Investing.com - Investing.com South Africa
Insmed CEO William Lewis sells shares worth $2.71 million By Investing.com - Investing.com Canada
Why INSM Stock Is Advancing Today - MSN
Insmed’s gene therapy poised to challenge DMD landscape after IND clearance - Yahoo Finance
Evolving Landscape of Cardiology Segment: Key Market Insights of Latest Published Rare Cardiovascular Diseases Report — Giant-Cell Arteritis, Pulmonary Arterial Hypertension, and Restrictive Cardiomyopathy | DelveInsight - GlobeNewswire Inc.
Capital CS Group LLC Buys New Stake in Insmed Incorporated (NASDAQ:INSM) - MarketBeat
Insmed (NASDAQ:INSM) Stock Price Up 6%Should You Buy? - MarketBeat
How Is The Market Feeling About Insmed? - Benzinga
Insmed issues preliminary revenue results, guidance for Arikayce - MSN
Insmed COO Roger Adsett sells $368,472 in stock By Investing.com - Investing.com Nigeria
Insmed chief commercial officer sells shares worth $659,800 By Investing.com - Investing.com Australia
Insmed chief legal officer sells $242,815 in common stock By Investing.com - Investing.com Australia
Insmed’s chief medical officer sells $725,820 in stock By Investing.com - Investing.com Nigeria
Insmed's chief medical officer sells $725,820 in stock By Investing.com - Investing.com Australia
Insmed CFO Sara Bonstein sells $392,601 in stock By Investing.com - Investing.com Australia
Insmed Incorporated (NASDAQ:INSM) Stock Holdings Boosted by Harbor Capital Advisors Inc. - MarketBeat
Insmed's chief medical officer sells $725,820 in stock - Investing.com India
Insmed CFO Sara Bonstein sells $392,601 in stock - Investing.com India
Insmed Incorporated (NASDAQ:INSM) CFO Sells $67,925.52 in Stock - MarketBeat
Insmed CEO William Lewis sells $995,012 in stock By Investing.com - Investing.com South Africa
Insmed CEO William Lewis sells $995,012 in stock - Investing.com India
Insmed chief people strategy officer sells shares worth $312,259 By Investing.com - Investing.com Canada
Roger Adsett Sells 2,444 Shares of Insmed Incorporated (NASDAQ:INSM) Stock - MarketBeat
Sara Bonstein Sells 3,470 Shares of Insmed Incorporated (NASDAQ:INSM) Stock - MarketBeat
Insmed Inc (INSM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):